Antigen-specific immune reactions to ischemic stroke.

PubWeight™: 0.86‹?›

🔗 View Article (PMC 4162361)

Published in Front Cell Neurosci on September 12, 2014

Authors

Xabier Urra1, Francesc Miró2, Angel Chamorro1, Anna M Planas3

Author Affiliations

1: Functional Unit of Cerebrovascular Diseases, Hospital Clínic Barcelona, Spain ; August Pi i Sunyer Biomedical Research Institute (IDIBAPS) Barcelona, Spain.
2: August Pi i Sunyer Biomedical Research Institute (IDIBAPS) Barcelona, Spain.
3: August Pi i Sunyer Biomedical Research Institute (IDIBAPS) Barcelona, Spain ; Department of Brain Ischemia and Neurodegeneration, Instituto de Investigaciones Biomédicas de Barcelona (IIBB), Consejo Superior de Investigaciones Científicas (CSIC) Barcelona, Spain.

Articles citing this

Stem Cell-Based Tissue Replacement After Stroke: Factual Necessity or Notorious Fiction? Stroke (2015) 0.83

Vascular, glial, and lymphatic immune gateways of the central nervous system. Acta Neuropathol (2016) 0.82

Lymphatics in Neurological Disorders: A Neuro-Lympho-Vascular Component of Multiple Sclerosis and Alzheimer's Disease? Neuron (2016) 0.81

Ischemia, Immunosuppression and Infection-Tackling the Predicaments of Post-Stroke Complications. Int J Mol Sci (2016) 0.80

DRα1-MOG-35-55 Reduces Permanent Ischemic Brain Injury. Transl Stroke Res (2016) 0.78

Partial MHC class II constructs as novel immunomodulatory therapy for stroke. Neurochem Int (2016) 0.76

Antigen Presentation After Stroke. Neurotherapeutics (2016) 0.76

Editorial: Mechanisms of neuroinflammation and inflammatory neurodegeneration in acute brain injury. Front Cell Neurosci (2015) 0.75

Immunomodulation after ischemic stroke: potential mechanisms and implications for therapy. Crit Care (2016) 0.75

Heterogeneity of B Cell Functions in Stroke-Related Risk, Prevention, Injury, and Repair. Neurotherapeutics (2016) 0.75

A Pathway Proteomic Profile of Ischemic Stroke Survivors Reveals Innate Immune Dysfunction in Association with Mild Symptoms of Depression - A Pilot Study. Front Neurol (2016) 0.75

Inflammation and Stroke: An Overview. Neurotherapeutics (2016) 0.75

Assessed and Emerging Biomarkers in Stroke and Training-Mediated Stroke Recovery: State of the Art. Neural Plast (2017) 0.75

How and why do T cells and their derived cytokines affect the injured and healthy brain? Nat Rev Neurosci (2017) 0.75

Articles cited by this

(truncated to the top 100)

Immunobiology of dendritic cells. Annu Rev Immunol (2000) 23.65

Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature (2004) 12.72

CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell (1999) 12.50

B lymphocytes secrete antigen-presenting vesicles. J Exp Med (1996) 11.53

Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev (2001) 7.60

The immunology of stroke: from mechanisms to translation. Nat Med (2011) 6.53

Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc Natl Acad Sci U S A (2002) 6.19

Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. J Cell Sci (2000) 5.57

NOX2 controls phagosomal pH to regulate antigen processing during crosspresentation by dendritic cells. Cell (2006) 5.35

Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. Immunity (2006) 5.32

Statins as a newly recognized type of immunomodulator. Nat Med (2000) 5.00

Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat Med (2009) 4.87

Three or more routes for leukocyte migration into the central nervous system. Nat Rev Immunol (2003) 4.76

Role of T lymphocytes and interferon-gamma in ischemic stroke. Circulation (2006) 4.61

Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Nat Med (2003) 4.47

Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper function. Nat Immunol (2005) 4.22

Cross-presentation by dendritic cells. Nat Rev Immunol (2012) 3.95

Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med (2003) 3.89

Spike timing-dependent plasticity of neural circuits. Neuron (2004) 3.76

Roles of heat-shock proteins in innate and adaptive immunity. Nat Rev Immunol (2002) 3.55

Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke (2009) 3.55

Myelination and support of axonal integrity by glia. Nature (2010) 3.54

Central tolerance: learning self-control in the thymus. Nat Rev Immunol (2005) 3.49

Splenic atrophy in experimental stroke is accompanied by increased regulatory T cells and circulating macrophages. J Immunol (2006) 3.28

Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology. Neurochem Int (2004) 3.16

Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat Med (1999) 3.13

S1P1 receptor signaling overrides retention mediated by G alpha i-coupled receptors to promote T cell egress. Immunity (2007) 3.05

Cross-presentation by intercellular peptide transfer through gap junctions. Nature (2005) 3.03

Oral tolerance. Immunol Rev (2011) 3.03

Oral tolerance can be established via gap junction transfer of fed antigens from CX3CR1⁺ macrophages to CD103⁺ dendritic cells. Immunity (2014) 2.99

The CD8alpha(+) dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens. J Exp Med (2002) 2.93

Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease. Brain Pathol (2008) 2.90

Cellular and genetic mechanisms of self tolerance and autoimmunity. Nature (2005) 2.89

Regulation of dendritic cell migration by CD74, the MHC class II-associated invariant chain. Science (2008) 2.88

Infection after acute ischemic stroke: a manifestation of brain-induced immunodepression. Stroke (2007) 2.87

A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis. J Exp Med (2001) 2.81

Acute ischaemic stroke and infection: recent and emerging concepts. Lancet Neurol (2008) 2.77

Stroke-induced immunodepression: experimental evidence and clinical relevance. Stroke (2007) 2.76

Cross-presentation in viral immunity and self-tolerance. Nat Rev Immunol (2001) 2.76

T- and B-cell-deficient mice with experimental stroke have reduced lesion size and inflammation. J Cereb Blood Flow Metab (2007) 2.75

High levels of a major histocompatibility complex II-self peptide complex on dendritic cells from the T cell areas of lymph nodes. J Exp Med (1997) 2.73

Peptides chaperoned by heat-shock proteins are a necessary and sufficient source of antigen in the cross-priming of CD8+ T cells. Nat Immunol (2005) 2.65

Hsp70 promotes antigen-presenting cell function and converts T-cell tolerance to autoimmunity in vivo. Nat Med (2003) 2.62

Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia. Am J Physiol Heart Circ Physiol (2005) 2.59

Lymphatic drainage of the brain and the pathophysiology of neurological disease. Acta Neuropathol (2008) 2.59

Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice. J Clin Invest (2002) 2.58

Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. Proc Natl Acad Sci U S A (1995) 2.44

Medical complications after stroke. Lancet Neurol (2010) 2.42

Activation of sphingosine 1-phosphate receptor-1 by FTY720 is neuroprotective after ischemic stroke in rats. Stroke (2009) 2.37

Blood-brain barrier breakdown in acute and chronic cerebrovascular disease. Stroke (2011) 2.37

Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology. Neuropathol Appl Neurobiol (2008) 2.32

Post-stroke infection: a systematic review and meta-analysis. BMC Neurol (2011) 2.29

Infarct volume is a major determiner of post-stroke immune cell function and susceptibility to infection. Stroke (2009) 2.28

Multiple roles for MMPs and TIMPs in cerebral ischemia. Glia (2005) 2.25

Drainage of brain extracellular fluid into blood and deep cervical lymph and its immunological significance. Brain Pathol (1992) 2.22

Carcinoembryonic antigen-related cell adhesion molecule 1 inhibits MMP-9-mediated blood-brain-barrier breakdown in a mouse model for ischemic stroke. Circ Res (2013) 2.21

Peripheral tolerance of CD8 T lymphocytes. Immunity (2005) 2.21

Systemic inflammation alters the kinetics of cerebrovascular tight junction disruption after experimental stroke in mice. J Neurosci (2008) 2.21

Early detrimental T-cell effects in experimental cerebral ischemia are neither related to adaptive immunity nor thrombus formation. Blood (2010) 2.17

Influenza virus infection aggravates stroke outcome. Stroke (2011) 2.13

Release of glial tissue-specific proteins after acute stroke: A comparative analysis of serum concentrations of protein S-100B and glial fibrillary acidic protein. Stroke (2000) 2.09

The immunology of acute stroke. Nat Rev Neurol (2012) 2.06

S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. Stroke (1997) 2.03

Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity. Mol Psychiatry (2013) 2.02

Autoimmune responses to the brain after stroke are associated with worse outcome. Stroke (2011) 1.95

Cutting edge: receptor-mediated endocytosis of heat shock proteins by professional antigen-presenting cells. J Immunol (1999) 1.92

CD4(+) and CD8(+) anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity. Blood (2002) 1.90

Fingolimod for the treatment of intracerebral hemorrhage: a 2-arm proof-of-concept study. JAMA Neurol (2014) 1.85

Mucosal administration of heat shock protein-65 decreases atherosclerosis and inflammation in aortic arch of low-density lipoprotein receptor-deficient mice. Circulation (2002) 1.80

Stroke-induced immunodepression and post-stroke infections: lessons from the preventive antibacterial therapy in stroke trial. Neuroscience (2008) 1.75

Association of serial biochemical markers with acute ischemic stroke: the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator Stroke Study. Stroke (2006) 1.73

Induction of mucosal tolerance to E-selectin prevents ischemic and hemorrhagic stroke in spontaneously hypertensive genetically stroke-prone rats. Stroke (2002) 1.71

The role of dendritic cells in autoimmunity. Nat Rev Immunol (2013) 1.68

Blood test detecting autoantibodies to N-methyl-D-aspartate neuroreceptors for evaluation of patients with transient ischemic attack and stroke. Clin Chem (2003) 1.67

Regulatory T cells are strong promoters of acute ischemic stroke in mice by inducing dysfunction of the cerebral microvasculature. Blood (2012) 1.64

Regulatory B cells limit CNS inflammation and neurologic deficits in murine experimental stroke. J Neurosci (2011) 1.63

Sensitization to brain antigens after stroke is augmented by lipopolysaccharide. J Cereb Blood Flow Metab (2005) 1.63

Fingolimod provides long-term protection in rodent models of cerebral ischemia. Ann Neurol (2010) 1.62

Monocytes are major players in the prognosis and risk of infection after acute stroke. Stroke (2009) 1.61

Heat shock protein 70 induced during tumor cell killing induces Th1 cytokines and targets immature dendritic cell precursors to enhance antigen uptake. J Immunol (1999) 1.60

Lipoproteins take their toll on the host. Curr Biol (1999) 1.59

The relationship between osteoarthritis and cardiovascular disease in a population health survey: a cross-sectional study. BMJ Open (2013) 1.55

Neutrophil infiltration increases matrix metalloproteinase-9 in the ischemic brain after occlusion/reperfusion of the middle cerebral artery in rats. J Cereb Blood Flow Metab (2003) 1.55

Pathways of fluid drainage from the brain--morphological aspects and immunological significance in rat and man. Brain Pathol (1992) 1.54

Human regulatory T cells and autoimmunity. Eur J Immunol (2008) 1.54

Neuroprotection by IL-10-producing MOG CD4+ T cells following ischemic stroke. J Neurol Sci (2005) 1.54

Transfer of central nervous system autoantigens and presentation in secondary lymphoid organs. J Immunol (2002) 1.54

B7 family checkpoint regulators in immune regulation and disease. Trends Immunol (2013) 1.53

Analysis of lymphocyte subsets in patients with stroke and their influence on infection after stroke. Stroke (2007) 1.50

Association between stroke and patients with pelvic inflammatory disease: a nationwide population-based study in Taiwan. Stroke (2011) 1.49

Immunologic tolerance to myelin basic protein decreases stroke size after transient focal cerebral ischemia. Proc Natl Acad Sci U S A (1997) 1.48

Neuroscience. Change in the brain's white matter. Science (2010) 1.46

Sphingosine-1-phosphate mediates migration of mature dendritic cells. J Immunol (2005) 1.46

Mechanisms of disease: atherosclerosis in autoimmune diseases. Nat Clin Pract Rheumatol (2006) 1.46

Cellular immunodepression preceding infectious complications after acute ischemic stroke in humans. Cerebrovasc Dis (2007) 1.42

Extracellular antigen processing and presentation by immature dendritic cells. Proc Natl Acad Sci U S A (1999) 1.41

Perivascular drainage of solutes is impaired in the ageing mouse brain and in the presence of cerebral amyloid angiopathy. Acta Neuropathol (2011) 1.41

Corticosteroids enhance the capacity of macrophages to induce Th2 cytokine synthesis in CD4+ lymphocytes by inhibiting IL-12 production. J Immunol (1998) 1.41

Nasal vaccination with myelin oligodendrocyte glycoprotein reduces stroke size by inducing IL-10-producing CD4+ T cells. J Immunol (2003) 1.40

Regulation of antigen presentation and cross-presentation in the dendritic cell network: facts, hypothesis, and immunological implications. Adv Immunol (2005) 1.40